Holen Sie sich die Stockscreener-App
1.54
3.14%
-0.05
Handel nachbörslich:
1.55
0.01
+0.65%
Schlusskurs vom Vortag:
$1.59
Offen:
$1.63
24-Stunden-Volumen:
694.36K
Relative Volume:
1.30
Marktkapitalisierung:
$62.75M
Einnahmen:
$68.68M
Nettoeinkommen (Verlust:
$-60.84M
KGV:
-0.9625
EPS:
-1.6
Netto-Cashflow:
$-38.42M
1W Leistung:
-4.35%
1M Leistung:
-46.90%
6M Leistung:
-79.13%
1J Leistung:
-73.40%
1-Tages-Spanne:
$1.525
$1.63
1-Wochen-Bereich:
$1.525
$1.705
52-Wochen-Spanne:
$1.525
$9.37
Pulmonx Corp Stock (LUNG) Company Profile
Firmenname
Pulmonx Corp
Sektor
Branche
Telefon
650-364-0400
Adresse
700 CHESAPEAKE DRIVE, REDWOOD CITY
Vergleichen Sie LUNG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.54 | 63.16M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 4.14B | 577.90M | 6.96 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-31 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-03-10 | Eingeleitet | D. Boral Capital | Buy |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-04 | Eingeleitet | Lake Street | Buy |
| 2024-02-23 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2023-02-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-07-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-12-08 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2021-03-25 | Eingeleitet | Piper Sandler | Neutral |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-10-26 | Eingeleitet | BofA Securities | Buy |
| 2020-10-26 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-10-26 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-10-26 | Eingeleitet | Stifel | Buy |
| 2020-10-26 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Pulmonx Corp Aktie (LUNG) Neueste Nachrichten
Volatility clustering patterns for Pulmonx Corporation2025 Price Targets & Safe Entry Zone Tips - Newser
Analyzing Pulmonx Corporation with risk reward ratio chartsFree Weekly Top Gainers Forecast Watchlist - Newser
Pulmonx Corporation stock trend outlook and recovery pathPortfolio Return Report & Fast Momentum Stock Entry Tips - Newser
Pulmonx at Canaccord Conference: Growth Plans Amid Challenges By Investing.com - Investing.com South Africa
Pulmonx at Canaccord Conference: Growth Plans Amid Challenges - Investing.com
Chart based exit strategy for Pulmonx CorporationFree Smart Trend Trading with Weekly Signals - Newser
Developing predictive dashboards with Pulmonx Corporation dataFuture Growth Stock Forecasting Strategy - Newser
After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Pulmonx (LUNG) - Yahoo Finance
What momentum shifts mean for Pulmonx CorporationTechnical Insight Guide for Safer Trades - Newser
What catalysts could drive Pulmonx Corporation stock higher in 2025Triple-digit returns - Jammu Links News
Pulmonx (NASDAQ:LUNG) Cut to Neutral at Piper Sandler - Defense World
Pulmonx (LUNG) Q2 Revenue Rises 15% - AOL.com
What the charts say about Pulmonx Corporation todayFree Triple Return Setup with Risk Control - Newser
Analysts Have Lowered Expectations For Pulmonx Corporation (NASDAQ:LUNG) After Its Latest Results - 富途牛牛
Pulmonx Corp SEC 10-Q Report - TradingView
Pulmonx Corporation (NASDAQ:LUNG) Q2 2025 Earnings Call Transcript - Insider Monkey
Pulmonx Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Pulmonx Corp (LUNG) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com
Nasdaq Surges Over 1%; Microsoft Posts Upbeat Earnings - Benzinga
Will GRDN price bounce be sustainableStrong Buy Opportunity with Volume Support - Newser
Should I buy Riverview Bancorp Inc. stock before earningsReal-Time AI Sentiment and Price Forecast - Newser
Pulmonx Corp (LUNG) Q2 2025 Earnings Call Highlights: Strong International Growth Amid US Challenges - Yahoo Finance
Stifel lowers Pulmonx target to $5 from $16, maintains Buy rating. - AInvest
Piper Sandler downgrades Pulmonx stock to Neutral on growth concerns - Investing.com India
Piper Sandler downgrades Pulmonx stock to Neutral on growth concerns By Investing.com - Investing.com Nigeria
What to expect from Pulmonx Corporation in the next 30 daysSwing Gain Strategy with Entry Forecast - Newser
CNB Financial Corporation stock retracement – recovery analysisPortfolio Risk Distribution Analysis Tool - Newser
Is Canada Goose Holdings Inc. showing signs of accumulationWeekly Return Plan for Conservative Traders - Newser
Tools to monitor Pulmonx Corporation recovery probabilityFree Real-Time Analysis With Entry Targets - Newser
Earnings call transcript: Pulmonx reports Q2 2025 revenue beat, stock gains - Investing.com Canada
Earnings call transcript: Pulmonx reports Q2 2025 revenue beat, stock gains By Investing.com - Investing.com South Africa
Pulmonx Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Pulmonx earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Option Care Health Inc. Building a Base Near SupportBreakout Confirmation With Entry Tracker Enabled - metal.it
Can trapped investors hope for a rebound in Sally Beauty Holdings Inc.Intraday Price Forecast Using Volume Models - Newser
Is Delek US Holdings Inc. stock ready for a breakoutVolume Confirmed Setup with Entry Confidence - Newser
Leading Lung Disease Treatment Company Pulmonx Showcases Growth Story at Major Healthcare Conference - Stock Titan
Why SL Green Realty Corp. stock is on top investor watchlistsSector Rotation and Stock Opportunity Analysis - Newser
Price Channel Expanding on Pulmonx Corporation’s ChartCapital Preserving Trade Plan Templates Shared - metal.it
Pulmonx Corp expected to post a loss of 40 cents a shareEarnings Preview - TradingView
Pulmonx (LUNG) Projected to Post Quarterly Earnings on Wednesday - Defense World
Pulmonx Corporation Stock Support and Resistance Levels You Should KnowWeekly Double Return List - metal.it
What makes HFBL stock price move sharplyInsider Strategy Insight - Newser
How Pulmonx Corporation stock performs during market volatilityWeekly Stock Picks with Trend Confidence - Newser
Pulmonx Corporation (NASDAQ:LUNG) Soars 47% But It's A Story Of Risk Vs Reward - simplywall.st
What analysts say about Pulmonx Corporation stockExceptional growth trajectory - jammulinksnews.com
Is Pulmonx Corporation a good long term investmentUnprecedented growth rates - jammulinksnews.com
What drives Pulmonx Corporation stock priceSuperior return velocity - jammulinksnews.com
Can Spring Valley Acquisition Corp. II Equity Right stock recover from recent declineDaily Breakout Picks - Newser
Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025 - The Manila Times
Pulmonx Sets Q2 Earnings Date: Leading Lung Disease Treatment Maker to Update Investors July 30 - Stock Titan
Finanzdaten der Pulmonx Corp-Aktie (LUNG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):